Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 35,316 |
|
|||||
| News | - | ||||||
| Day High | 13.49 | Low High |
|||||
| Day Low | 12.3304 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cidara Therapeutics Inc | CDTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.27 | 2.17% | 12.69 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.71 | 12.3304 | 13.49 | 12.69 | 12.42 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,347 | 35,316 | $ 12.88 | $ 454,785 | - | 10.004 - 27.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:58 | 6 | $ 12.69 | USD |
Cidara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.16B | 90.43M | - | 63.91M | -22.93M | -0.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cidara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.00 | 13.49 | 11.40 | 12.02 | 34,648 | 0.69 | 5.75% |
| 1 Month | 11.75 | 14.1206 | 10.50 | 12.28 | 49,744 | 0.94 | 8.00% |
| 3 Months | 13.888 | 24.40 | 10.004 | 16.15 | 616,212 | -1.20 | -8.63% |
| 6 Months | 14.20 | 24.40 | 10.004 | 15.53 | 639,873 | -1.51 | -10.63% |
| 1 Year | 26.60 | 27.60 | 10.004 | 17.67 | 575,701 | -13.91 | -52.29% |
| 3 Years | 41.20 | 47.80 | 8.00 | 24.29 | 797,517 | -28.51 | -69.20% |
| 5 Years | 34.20 | 89.00 | 8.00 | 31.46 | 636,311 | -21.51 | -62.89% |
Cidara Therapeutics Description
| Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. |
